Starget Pharma
PrivateLast Round
Series A
Feb 18, 2026
Total Funding Raised
$33.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Starget Pharma is a biotechnology company that develops AI-driven peptide radioligand therapies for the imaging and treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Starget Pharma Comparables
Compare Starget Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alpha-9 Oncology | 85% | |
| Ratio Therapeutics Inc. | 81% | |
| Aktis Oncology | 80% |
Starget Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 18, 2026 | ||||
| Seed | Oct 23, 2024 | ||||
| Series A | Nov 30, 2021 |
Starget Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The University of Texas MD Anderson Cancer Center | Series A, Seed |
| Cancer Focus Fund | Series A, Seed |
| Louisiana Economic Development Corporation | Series A |
| Biomedical Research Foundation of Northwest Louisiana | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Jun 16, 2026
Monthly visitors increased 2603% MoM, reaching 1.1K.
Recent news
Latest coverage and updates
- is_developingSep 20, 2026
Starget Pharma Inc. is developing Smart Targeted Radioligands on Jul 1st '26.
- hiresAug 5, 2026
Starget Pharma Inc. hired Oliver Sartor as Scientific Advisory Board on Jul 28th '26.
- hiresAug 5, 2026
Starget Pharma Inc. hired Michael Hofman as Scientific Advisory Board on Jul 28th '26.
Starget Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Starget Pharma's valuation, stock price, and market status.
Is Starget Pharma a public or private company?
Starget Pharma is a private company.
What is the current stock price of Starget Pharma?
Starget Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Starget Pharma worth (valuation)?
Valuation information for Starget Pharma is not publicly available.
Can I buy Starget Pharma stock?
Starget Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Starget Pharma's last funding round?
Starget Pharma's most recent funding round was Series A on February 18, 2026.
Who are the main investors in Starget Pharma?
Key investors in Starget Pharma include Cancer Focus Fund.
Will Starget Pharma IPO soon?
No public IPO plans have been announced for Starget Pharma.
How can I track Starget Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Starget Pharma's secondary market activity and sign up for updates.